Fusion Pharmaceuticals Stock Forecast - Market Facilitation Index

FUSNDelisted Stock  USD 3.75  0.33  8.09%   
Fusion Stock Forecast is based on your current time horizon.
  
Fusion Pharmaceuticals has current Market Facilitation Index of 0.33. Market Facilitation Index is simply a difference between period high and low prices divided by period trading volume.
Check Fusion Pharmaceuticals VolatilityBacktest Fusion PharmaceuticalsInformation Ratio  

Fusion Pharmaceuticals Trading Date Momentum

On December 12 2024 Fusion Pharmaceuticals was traded for  3.75  at the closing time. The top price for the day was 4.08  and the lowest listed price was  3.75 . There was no trading activity during the period 0.0. Lack of trading volume on December 12, 2024 did not affect price variability. The overall trading delta against the current closing price is 8.80% .
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
Compare Fusion Pharmaceuticals to competition

View Fusion Pharmaceuticals Related Equities

 Risk & Return  Correlation

Fusion Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Fusion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fusion Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Fusion Pharmaceuticals stock market strength indicators, traders can identify Fusion Pharmaceuticals entry and exit signals to maximize returns.

Fusion Pharmaceuticals Risk Indicators

The analysis of Fusion Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Fusion Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting fusion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Fusion Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fusion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fusion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Fusion Stock

  0.48PG Procter GamblePairCorr
  0.45MMM 3M Company Sell-off TrendPairCorr
  0.44MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.41VZ Verizon Communications Fiscal Year End 28th of January 2025 PairCorr
  0.4MSFT Microsoft Aggressive PushPairCorr
The ability to find closely correlated positions to Fusion Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fusion Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fusion Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fusion Pharmaceuticals to buy it.
The correlation of Fusion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fusion Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fusion Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fusion Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Fusion Stock

If you are still planning to invest in Fusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fusion Pharmaceuticals' history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities